Editorial · 4 Sep 2021
EditorialPublished 29 Jun 2021
An Editorial Note on Proteochemometrics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
One of the most important phases of a drug discovery campaign is the discovery of a potent inhibitor to a target driving the disease phenotype. Experimental design, make, test cycles seek to optimize initial hits to lead compounds by optimizing the protein-ligand binding affinity
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 13 Jan 2021
Editorial Note on New Antibiotics Discovery
Editorial · 18 Feb 2022
Editorial Note on a Drug Action
Editorial · 6 Oct 2021
Editorial Note on Food-Drug Interactions
Editorial · 5 Oct 2021
EDITORIAL NOTE ON BLACK TRIANGLE DRUGS
More from this journal
The newest in Asian Journal of Pharmaceutical Technology and Innovation.
Article · 21 Jun 2024
Examining biopharmaceuticals in modern medicine and its applications.
Article · 21 Jun 2024
Evaluating toxicological considerations in biopharmaceutical development.
Article · 21 Jun 2024
Assessing the impact of regulatory changes on pharmacy practice.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAsian Journal of Pharmaceutical Technology and Innovation
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Dr. Swetha Pothula”
